Alnylam and Collaborators Publish Results from Phase I Clinical Trial with RNAi Therapeutic

News   Jan 31, 2013

 
Alnylam and Collaborators Publish Results from Phase I Clinical Trial with RNAi Therapeutic
 
 
 
 

RELATED ARTICLES

Understanding the Cellular Systems that Hold Back the Spread of Cancer

News

Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

READ MORE

Potential Barcode Identified for a Form of Alcoholic Liver Disease

News

NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.

READ MORE

RNA Molecules Lives Are 10 Times Shorter Than Previously Thought

News

A research group at the Biozentrum of the University of Basel has developed a new method to measure the half-life of RNA molecules.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE